Written medicines information for South African HIV/AIDS patients: Does it enhance understanding of co-trimoxazole therapy?

Health Education Research

Volumn 22, Issue 1, 2007, Pages 37-48

  Mansoor, Leila ^a   Dowse, Ros ^a  

^a RHODES UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANOREXIA; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DIZZINESS; DRUG INFORMATION; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; NAUSEA AND VOMITING; PATIENT INFORMATION; PNEUMOCYSTIS CARINII; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RECALL; SOUTH AFRICA;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; PAMPHLETS; PATIENT EDUCATION; SOCIOECONOMIC FACTORS; SOUTH AFRICA; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 33846369556     PISSN: 02681153     EISSN: 14653648     Source Type: Journal    
DOI: 10.1093/her/cyl039     Document Type: Article

References (45)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). AIDS Epidemic Update: December 2005. Available at: http://www.unaids. org/epi/2005/doc/EPIupdate2005_pdf_en/epi-update2005_ en.pdf. Accessed: 17 May 2006.
2. AVERT. HIV and AIDS in Africa. Available at: http://www.avert.org/ aafrica.htm. Accessed: 14 October 2004.
3. AVERT. AIDS Around the World. Available at: http://www.avert.org/ aroundworld.htm. Accessed: 14 October 2004.
4. Jones S, Clarbour J, Erskine D. Patient information leaflets for HIV positive patients. Pharm J 1990; 45: 308-9.
5. Kitching JB. Patient information leaflets-the state of the art. J Soc Med 1990; 83: 298-300.
6. Kenny T, Wilson RG, Purves IN et al. A PIL for every ill? Patient information leaflets (PILs): a review of past, present and future use. Fam Pract 1998; 15: 471-9.
7. Culbertson VL, Arthur TG, Rhodes PJ et al. Consumer preferences for verbal and written medication information. Drug Intell Clin Pharm 1998; 22: 390-6.
8. Kessler DA. Communicating with patients about their medications. N Engl J Med 1991; 325: 1650-2.
9. Koo MM, Krass I, Aslani P. Factors influencing consumer use of written drug information. Ann Pharmacother 2003; 37: 259-67.
10. Mayeaux EJ, Murphy PW, Arnold C et al. Improving patient education for patients with low literacy skills. Am Fam Physician 1996; 53: 205-11.
11. Dixon-Woods M. Writing wrongs? An analysis of published discourses about the use of patient information leaflets. Soc Sci Med 2001; 52: 1417-32.
12. Ormrod J, Robinson M. How readable are health education leaflets? Health Visit 1994; 67: 424-5.
13. Basara LR, Jeurgens JP. Patient package insert readability and design. Am Pharm 1994; 34: 48-53.
14. Morris LA, Halperin JA. Knowledge of written drug information on patient knowledge and compliance: a literature review. Am J Public Health 1979; 69: 47-52.
15. Bradley B, Singleton M, Li Wan Po A. Readability of patient information leaflets on over-the-counter (OTC) medicines. J Clin Pharm Ther 1994; 19: 7-15.
16. Le Roux C. Patient information leaflets as an education tool. S Afr Pharm J 1997; 6: 174-5.
17. Bernardini C, Ambrogi V, Perioli L et al. Comprehensibility of the package leaflets of all medicinal products for human use: a questionnaire survey about the use of symbols and pictograms. Pharmacol Res 2000; 41: 679-88.
18. Turnbull A. How nurses can develop good patient information leaflets. Nurs Times 2003; 99: 26-7.
19. Eaton ML, Holloway RL. Patient comprehension of written drug information. Am J Hosp Pharm 1980; 37: 240-3.
20. Mansoor L, Dowse R. Effect of pictograms on readability of patient information materials. Ann Pharmacother 2003; 37: 1003-9.
21. Gal I, Prigat A. Why organizations continue to create patient information leaflets with readability and usability problems: an exploratory study. Health Educ Res 2005; 20: 485-93.
22. Buck ML. Providing patients with written medication information. Ann Pharmacother 1998; 32: 962-9.
23. Rolland PD. Reading level of drug information printouts: a barrier to effective communication of patient medication information. Drug Inf J 2000; 34: 1329-38.
24. Dowse R, Ehlers MS. The evaluation of pharmaceutical pictograms in a low-literate South African population. Patient Educ Couns 2001; 45: 87-99.
25. Mansoor L, Dowse R. Design and evaluation of a new pharmaceutical pictogram sequence to convey medicine usage. Ergon SA 2004; 16: 29-41.
26. Magurno AB, Wogalter MS, Wolff JS et al. Iterative test and development of pharmaceutical pictorials. Ergon Des 1994; 4: 360-2.
27. Hanson EC, Hartzema A. Evaluating pictograms as an aid for counseling elderly and low-literate patients. J Pharm Mark Manage 1995; 9: 41-54.
28. Reed LA, Hoffman LG. Pictorial cues and enhancement of patient recall of instructions or information. J Am Optom Assoc 1986; 4: 312-5.
29. Ngoh LN, Shepherd MD. Design, development, and evaluation of visual aids for communicating prescription drug instructions to nonliterate patients in rural Cameroon. Patient Educ Couns 1997; 30: 245-61.
30. Sojourner RJ, Wogalter MS. The influence of pictorials on evaluations of prescription medication instructions. Drug Inf J 1997; 31: 963-72.
31. Dowse R, Ehlers MS. Medicine labels incorporating pictograms: do they influence understanding and adherence? Patient Educ Couns 2005; 58: 63-70.
32. Houts PS, Witmer JT, Egeth HE et al. Using pictographs to enhance recall of spoken medical instructions II. Patient Educ Couns 2001; 43: 231-42.
33. Houts PS, Bachrach R, Witmer JT et al. Using pictographs to enhance recall of spoken medical instructions. Patient Educ Couns 1998; 35: 83-8.
34. South Africa info. The Official Gateway. Available at: http:// www.southafrica.info/ess_info/sa_glance/health/health.htm. Accessed: 6 June 2005.
35. Statistics South Africa. Census 2001. Primary Tables Eastern Cape. Available at: http://www.statssa.gov.za/ census01/HTML/ECPrimary.pdf. Accessed: 20 October 2005.
36. Sless D, Wiseman R. Writing About Medicines for People. Usability Guidelines for Consumer Medicines Information, 2nd edn. Canberra: Australian Government Publishing Service, 1997.
37. Department of Health, Republic of South Africa. General Regulations Made in Terms of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965), As Amended. Available at: http://www.doh.gov.za/search/index.html. Accessed: 20 June 2003.
38. Mwingira B. Development and assessment of medicines information for antiretroviral therapy in Sub-Saharan Africa. MSc (Pharmacy) Thesis. Grahamstown, South Africa: Rhodes University, 2004.
39. Fry E. Fry's readability graph: clarification, validity, and extension to level 17. J Read 1977; 21: 242-52.
40. Winfield AJ, Owen CW. Information leaflets: a means of improving patient compliance. Br J Pharm Prac 1990; 6: 206-9.
41. Johnson A, Stanford J. Written and verbal information versus verbal information only for patients being discharged from acute hospital settings to home: systematic review. Health Educ Res 2005; 20: 423-9.
42. Doak CC, Doak LG, Root JH. Teaching patients with low-literacy skills. Philadelphia, PA: JB Lippincott Co., 1996.
43. Clerehan R, Buchbinder R, Moodie J. A linguistic framework for assessing the quality of written patient information: it use in assessing methotrexate information for rheumatoid arthritis. Health Educ Res 2005; 20: 334-44.
44. Wiseman S, MacLeod CM, Lootsteen PJ. Picture recognition improves with subsequent verbal information. J Exp Psychol Learn Mem Cogn 1985; 11: 588-95.
45. Haynes RB, Taylor DW, Sackett DL et al. Can simple clinical measurements detect patient noncompliance? Hypertension 1980; 2: 757-64.